Alert: Major Price Advance (1/2/24)-Abeona Therapeutics Inc (NASDAQ: ABEO).


Abeona Therapeutics Inc (NASDAQ: ABEO) stock closed at $5.53 on 1/2/24 after a major increase of 10.4%. Moreover, above average trading volume at 146% of normal accompanied the advance. The stock has risen 15.7% during the last week and has been exceptionally strong relative to the market over the last nine months.


Current PriceTarget Research Rating

ABEO is expected to continue to be Value Creation neutral reflecting capital returns that are forecasted to be in line with the cost of capital.

Abeona Therapeutics has a current Value Trend Rating of C (Low Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Abeona Therapeutics has a very low Appreciation Score of 1 but a very high Power Rating of 93, triggering the Low Neutral Value Trend Rating.

Rating Review

In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.

Be the first to comment

Leave a Reply

Your email address will not be published.